These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1948261)

  • 1. A 5-year surveillance of sensitivity in vivo of Plasmodium falciparum to pyronaridine/sulfadoxine/pyrimethamine in Diaoluo area, Hainan Province.
    Shao BR; Huang ZS; Shi XH; Meng F
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):65-7. PubMed ID: 1948261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the sensitivity of Plasmodium falciparum to pyronaridine/sulfadoxine/pyrimethamine in vitro].
    Han XL; Liu DQ; Feng XP
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(1):8-10. PubMed ID: 12567461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan].
    Yang H; Yang P; Yang Y
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1994; 12(2):140-2. PubMed ID: 7955166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of amodiaquine, sulfadoxine-pyrimethamine, and combinations of these drugs for treating chloroquine-resistant falciparum malaria in Hainan Island, China.
    Huang OL; Ouyang WC; Zhou JX; Wu Z; Zhang KY; Huang JK; Cai XZ; Pang XJ; Fu SG; Wang XF
    Bull World Health Organ; 1988; 66(3):353-8. PubMed ID: 3048759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the new antimalarial drug pyronaridine: a review.
    Chen C; Zheng X
    Biomed Environ Sci; 1992 Jun; 5(2):149-60. PubMed ID: 1642789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
    Ghosh SK; Yadav RS; Sharma VP
    Indian J Malariol; 1992 Dec; 29(4):211-8. PubMed ID: 1291342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resistance of Plasmodium falciparum to 3 antimalarials in Turbo (Antioquia, Colombia), 1998].
    Blair S; Lacharme LL; Fonseca JC; Tobón A
    Rev Panam Salud Publica; 2001 Jan; 9(1):23-9. PubMed ID: 11253274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
    Kamugisha J; Kipp W; Burnham G
    Trop Geogr Med; 1994; 46(6):364-5. PubMed ID: 7892705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chloroquine and fansidar resistance of Plasmodium falciparum now also in Ghana].
    Kupferschmidt HG; Schröder K; Beltzner B
    Angew Parasitol; 1988 Nov; 29(4):211-3. PubMed ID: 3072886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay.
    Garg MR; Gogtay NJ; Kshirsagar NA
    J Assoc Physicians India; 1996 Oct; 44(10):683-5. PubMed ID: 9251339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first report of Plasmodium falciparum resistant to chloroquine plus sulphadoxine/pyrimethamine in Rwanda.
    Giboda M; Vanista J; Dastych P
    Trans R Soc Trop Med Hyg; 1988; 82(3):383. PubMed ID: 3068850
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
    J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic efficacy of sulfadoxine/pyrimethamine against Plasmodium falciparum in Yemen.
    Al-Kabsi AM; Al-Shamahy HA; Al-Harazy AH; Harmal NS
    Med Princ Pract; 2009; 18(1):62-6. PubMed ID: 19060494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrimethamine-sulfadoxine (Fansidar) resistance in a non-immune Kenyan--a case report.
    Nevill CG; Gardner A
    East Afr Med J; 1991 Feb; 68(2):149-51. PubMed ID: 2040235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
    Alifrangis M; Enosse S; Khalil IF; Tarimo DS; Lemnge MM; Thompson R; Bygbjerg IC; Rønn AM
    Am J Trop Med Hyg; 2003 Dec; 69(6):601-6. PubMed ID: 14740875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya.
    Spencer HC; Watkins WM; Sixsmith DG; Koech DK; Chulay JD
    Bull World Health Organ; 1984; 62(4):615-21. PubMed ID: 6386209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh.
    Marma AS; Mita T; Eto H; Tsukahara T; Sarker S; Endo H
    Parasitol Int; 2010 Jun; 59(2):178-82. PubMed ID: 20097306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of combined use of pyronaridine, sulfadoxine and pyrimethamine in the treatment of falciparum malaria on Hainan Island].
    Pang XJ; Liu QJ; Chen QY; Cai XZ; Lin KH; Ou FZ; Liu YP; Fu SG; Liu XM; Liu HH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1988; 6(4):289-91. PubMed ID: 3075525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.